Targeting tumor angiogenic vasculature using polymer–RGD conjugates
- 1 January 2005
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 102 (1) , 191-201
- https://doi.org/10.1016/j.jconrel.2004.09.023
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- The dawning era of polymer therapeuticsNature Reviews Drug Discovery, 2003
- Specialization of tumour vasculatureNature Reviews Cancer, 2002
- The potential role of antivascular therapy in the adjuvant and neoadjuvant treatment of cancerSeminars in Oncology, 2001
- Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and InhibitorsAngewandte Chemie International Edition in English, 1998
- αv Integrins as receptors for tumor targeting by circulating ligandsNature Biotechnology, 1997
- Gamma Scintigraphy of a123I-Labelled N-(2-Hydroxypropyl)Methacrylamide Copolymer-Doxorubicin Conjugate Containing Galactosamine Following Intravenous Administration to Nude Mice Bearing Hepatic Human Colon CarcinomaJournal of Drug Targeting, 1996
- Influence of molecular weight on passive tumour accumulation of a soluble macromolecular drug carrierEuropean Journal Of Cancer, 1995
- Requirement of Vascular Integrin α v β 3 for AngiogenesisScience, 1994
- Transport of fluid and macromolecules in tumorsMicrovascular Research, 1991
- Surface properties of copolymers of alkyl methacrylates with, methoxy (polyethylene oxide) metiiacrylates and their application as protein-resistant coatingsBiomaterials, 1990